Sepsis and septic shock are significant health issues in the United States. Novel treatment options focusing on mitigating the dysregulated host response while reducing the need for vasopressor support are needed. This review discusses ascorbic acid, thiamine, and steroids as monotherapy and in combination for the treatment of sepsis and septic shock.
Summary:
The results of clinical studies using ascorbic acid, thiamine, and steroids as monotherapy or in combination are reviewed. High doses of IV ascorbic acid improved organ failure evidenced by changes in SOFA scores, declining CRP and PCT levels, and reduced vasopressor use. Thiamine initiation improved lactate levels in thiamine deficient patients in one study and demonstrated quicker lactate clearance and lower 28-day mortality in another study. Steroid studies demonstrated greatest benefit when initiating hydrocortisone and fludrocortisone early in septic shock. Combination therapy with ascorbic acid, thiamine and steroids reduced hospital mortality and vasopressor use in sepsis and septic shock in a small single-center study.
Conclusion:
Initial studies in patients with sepsis and septic shock demonstrated beneficial effects of ascorbic acid, thiamine, and steroids as monotherapy or in combination without safety concerns. However, the efficacy and safety of these therapies warrant further validation in larger clinical studies.
RhodesAEvansLAlhazzaniW, et al.Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2016. Crit Care Med. 2017;34:488–552.
3.
SingerMDeutschmanCSSeymourCW, et al.The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810.
4.
AuchetTRegnierMGirerdN, et al.Outcome of patients with septic shock and high dose vasopressor therapy. Ann Intensive Care. 2017;7:43.
5.
FowlerAAIIISyedAAKnowlsonS, et al.Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014;12:32.
6.
ZabetMHMohammadiMRamezaniM, et al.Effect of high-dose ascorbic acid on vasopressor’s requirement in septic shock. J Res Pharm Pract. 2016;5(2):94–100.
7.
DonninoMWAndersenLWChaseM, et al.Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study. Crit Care Med. 2016;44(2):360–367.
8.
MoskowitzAAndersenLWCocchiMN, et al.Thiamine as a renal protective agent in septic shock. a secondary analysis of a randomized, double-blind, placebo-controlled trial. Ann Am Thorac Soc. 2017;14(5):737–741.
9.
WoolumJAbnerEKellyA, et al.Effect of thiamine administration on lactate clearance and mortality in patients with septic shock. Crit Care med. 2018;46(11):1747–1752.
10.
AnnaneDSébilleVCharpentierC, et al.Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7):862–871.
11.
SprungCLAnnaneDKehD, et al.Hydrocortisone therapy for patients with septic shock. NEJM. 2008;358(2):111–124.
12.
KehDTripsEMarxG, et al.Effect of hydrocortisone on development of shock among patients with severe sepsis, The HYPRESS randomized clinical trial. JAMA. 2016;316(17):1775–1785.
13.
VenkateshBFinferSCohenJ, et al.Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378(9):797–808. ADRENAL study
14.
AnnaneDRenaultABrun-BuissonC, et al.Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378(9):809–818.
15.
MarikPEKhangooraVRiveraR, et al.Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock. A retrospective before-after study. Chest. 2017;151(6):1229–1238.
16.
ArmourJTymlKLidingtonD, et al.Ascorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat. J Appl Physiol. 2001;90(3):795–803.
17.
WuFWilsonJXTymlK. Ascorbate protects against impaired arteriolar constriction in sepsis by inhibiting inducible nitric oxide synthase expression. Free Radic Biol Med. 2004;37(8):1282–1289.
18.
CostaNAGutALde Souza DornaM, et al.Serum thiamine concentration and oxidative stress as predictors of mortality in patients with septic shock. J Crit Care. 2014;29(2):249–252.
19.
MeduriGUMuthiahMPCarratuP, et al.Nuclear factor- kappaB- and glucocorticoid receptor alpha- mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome: evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation. 2005;12(6):321–338.
20.
WilsonJX. Evaluation of vitamin C for adjuvant sepsis therapy. Antioxid Redox Signal. 2013;19(17):2129–2140.
21.
MayJMHarrisonFE. Role of vitamin C in the function of the vascular endothelium. Antioxid Redox Signal. 2013;19(17):2068–2083.
22.
GalleyHFDaviesMJWebsterNR. Ascorbyl radical formation in patients with sepsis: effect of ascorbate loading. Free Rad Biol Med. 1996;20(1):139–143.
23.
CarrAFreiB. Does vitamin C act as a pro-oxidant under physiological conditions?FASEB J. 1999;13(9):1007–1024.
24.
CarrACFreiB. Toward a new recommended dietary allowance for ascorbic acid based on antioxidant and health effects in humans. Am J Clin Nutr. 1999;69(6):1086–1107.
KimSR. Ascorbic acid reduces HMGB1 secretion in lipopolysaccharide-activated RAW 264.7 cells and improves survival rate in septic mice by activation of Nrf2/ HO-1 signals. Biochem Pharmacol. 2015;95(4):279–289.
27.
ManningJMitchellBAppaduraiDA, et al.Vitamin C promotes maturation of T-cells. Antioxid Redox Signal. 2013;19(17):2054–2067.
28.
HuntCChakravortyNKAnnanG, et al.The clinical effects of vitamin C supplementation in elderly hospitalized patients with acute respiratory infections. Int J Vitam Nutr Res. 1994;64(3):212–219.
29.
SchorahCJDowningCPiripitsiA, et al.Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr. 1996;63(5):760–765.
30.
DonninoMWCarneyECocchiMN, et al.Thiamine deficiency in critically ill patients with sepsis. J Crit Care. 2010;25(4):576–581.
31.
CruickshankAMTelferABShenkinA. Thiamine deficiency in the critically ill. Intensive Care Med. 1988;14(4):384–387.
32.
MallatJLemyzeMTheveninD. Do not forget to give thiamine to your septic shock patient!J Thorac Dis. 2016;8(6):1062–1066. doi:10.21037/jtd.2016.04.32.
33.
ManzanaresWHardyG. Thiamine supplementation in the critically ill. Curr Opin Clin Nutr Metab Care. 2011;14(6):610–617.
34.
GordonACMasonAJThirunavukkarasuN, et al.Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316(5):509–518.
35.
HayesMAYauEHHindsCJ, et al.Symmetrical peripheral gangrene: association with noradrenaline administration. Intensive Care Med. 1992;18(7):433–436.
36.
DunserMWWenzelVHasibederWR. Ischemic skin lesions and microcirculatory collapse during vasopressin therapy: a possible role of the microcirculation?Acta Anaesthesiol Scand. 2006;50(5):637–638.
37.
SenoTInoueNMatsuiK, et al.Functional expression of sodium-dependent ascorbic acid transporter 2 in human endothelial cells. J Vasc Res. 2004;41(4):345–351.
38.
MasseyLKLiebmanMKynast-GalesS. Ascorbate increases human oxaluria and kidney stone risk. J Nutr. 2005;135(7):1673–1677.
39.
WandzilakTRD’AndreSDDavisPA, et al.Effect of high dose vitamin C on urinary oxalate levels. J Urol. 1994;151(4):834–837.
40.
HoppeBBeckBBMillinerD. The primary hyperoxalurias. Kidney Int. 2009;75(12):1264–1271.
41.
SidhuHGuptaRThindSK, et al.Oxalate metabolism in thiamine-deficient rats. Ann Nutr Metab. 1987;31(6):354–361.
42.
Ortiz-AlvaradoOMiyaokaRKriedbergC, et al.Pyridoxine and dietary counseling for the management of idiopathic hyperoxaluria in stone-forming patients. Urology. 2011;77(5):1054–1058.
43.
WoolumJOAbnerERKellyAN, et al.Effect of thiamine administration on lactate clearance and mortality in patients with septic shock. Crit Care Med. 46(11):1747–1752.
44.
ButterworthRF: Maternal thiamine deficiency: still a problem in some world communities. Am J Clin Nutr. 2001;74(6):712–713.
SimonJAHudesES. Relation of serum ascorbic acid to serum vitamin B12, serum ferritin and kidney stones in US adults. Arch Intern Med. 1999;159(6):619–624.
47.
TraxerOHuetBPoindexterJ, et al.Effect of ascorbic acid consumption on urinary stone risk factors. J Urol. 2003;170(2 Pt 1):397–401.
48.
PadayattySJSunAYChenQ, et al.Vitamin C: intravenous use by complementary and alternative medicine practioners and adverse effects. PLoS One. 2010;5(7):E1141.
49.
SmithKEBrownCSManningBM, et al.Accuracy of point-of-care blood glucose level measurements in critically ill patients with sepsis receiving high-dose intravenous Vitamin C. Pharmacotherapy. 2018;38(11):1155–1161. doi:10.1002/phar.2182.
50.
Oudemans-van StraatenHMElbersPWGSpoelstra-de ManAME. How to give Vitamin C a cautious but fair chance in severe sepsis. Chest. 2017;151(6):1199–1200. doi:10.1016/j.chest.2017.01.008.
